ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma

Approximately 90% of limited-stage Hodgkin lymphoma (HL) patients are projected to be cured with standard therapy, but many do not live their expected life span because of late treatment–related complications. New treatment paradigms are needed to reduce the use of radiation therapy (RT) as well as...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Adv
Main Authors: Park, Steven I., Shea, Thomas C., Olajide, Oludamilola, Reddy, Nishitha M., Budde, Lihua E., Ghosh, Nilanjan, Deal, Allison M., Noe, Jeanne F., Ansell, Stephen M.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2020
Teme:
Lymphoid Neoplasia
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284091/
https://ncbi.nlm.nih.gov/pubmed/32516414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001871
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki